Literature DB >> 31359199

Laparoscopic sleeve gastrectomy is an independent predictor of poor follow-up and reaching ≤ 40% excess body weight loss at 1, 2, and 3 years after bariatric surgery.

Anahita Jalilvand1, Alecia Blaszczak2, Jane Dewire2, Andrew Detty2, Bradley Needleman1, Sabrena Noria3.   

Abstract

INTRODUCTION: Contrary to published literature, our institutional data demonstrated reduced weight loss following laparoscopic sleeve gastrectomy (LSG) compared to gastric bypass (LRYGB). The purpose of this study was to determine if known predictors of poor weight loss accounted for this discrepancy at a large volume center.
METHODS: All patients undergoing primary LSG (n = 322) and LRYGB (n = 249), from 2014 to 2016, at a single institution were retrospectively reviewed. Baseline medical, socioeconomic, and follow-up data (6, 12, 24, and 36 months) were obtained. The first aim characterized differences in LSG and LRYGB. The second objective determined predictors of experiencing the lowest or highest quartile of excess body weight loss [(EBWL), (%EBWL-25th, %EBWL-75th)] at 12, 24, and 36 months. Thirdly, predictors of poor weight loss within sleeve gastrectomy were characterized.
RESULTS: In comparison to patients undergoing LRYGB, LSG patients demonstrated lower baseline BMI (47.9 ± 8.2 vs. 51.5 ± 10.1, p < 0.0005), lower incidences of obesity-related comorbidities (p < 0.05), were more likely to have higher education (p = 0.02), and were associated with no-shows up to 2 years post-operatively. LSG remained a strong independent predictor of %EBWL-25th at 12 months (OR = 5.2, p < 0.005), 24 months (OR = 5.3, p < 0.005), and 36 months (OR = 7.3, p = 0.006), after adjusting for comorbidities, education, and no-shows. Predictors of poor weight loss after LSG included hypertension, African American race, major depression, no-shows at 6 and 12 months. Within patients associated with these characteristics, the relative risk of experiencing poor weight loss was significantly higher following LSG compared to LRYGB at 12 months (60% vs. 25.0%, p < 0.05), 24 months (43% vs. 18%, p < 0.05), and 36 months (70% vs. 21%, p < 0.05).
CONCLUSIONS: LSG remained an independent predictor of poor weight loss at all post-operative time points. Furthermore, the risk of experiencing poor weight loss was significantly higher following LSG compared to LRYGB for patients with high-risk characteristics.

Entities:  

Keywords:  Bariatric surgery; Gastric bypass; Post-operative follow-up; Sleeve gastrectomy; Weight loss

Mesh:

Year:  2019        PMID: 31359199     DOI: 10.1007/s00464-019-07023-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  20 in total

1.  Comparison of Outcomes Between Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Lebanese Bariatric Surgical Practice.

Authors:  Hanaa Dakour Aridi; Georges Khazen; Bassem Y Safadi
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  A 7-Year Clinical Audit of 1107 Cases Comparing Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and Mini-Gastric Bypass, to Determine an Effective and Safe Bariatric and Metabolic Procedure.

Authors:  Gurvinder S Jammu; Rajni Sharma
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

Review 3.  Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies.

Authors:  Saeed Shoar; Alan A Saber
Journal:  Surg Obes Relat Dis       Date:  2016-08-18       Impact factor: 4.734

4.  Effectiveness and Safety of Sleeve Gastrectomy, Gastric Bypass, and Adjustable Gastric Banding in Morbidly Obese Patients: a Multicenter, Retrospective, Matched Cohort Study.

Authors:  Kemal Dogan; Ralph P M Gadiot; Edo O Aarts; Bark Betzel; Cees J H M van Laarhoven; Laser U Biter; Guido H H Mannaerts; Theo J Aufenacker; Ignace M C Janssen; Frits J Berends
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

5.  Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients.

Authors:  Jose Luis Leyba; Salvador Navarrete Aulestia; Salvador Navarrete Llopis
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

6.  Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss.

Authors:  M Ignat; M Vix; I Imad; A D'Urso; S Perretta; J Marescaux; D Mutter
Journal:  Br J Surg       Date:  2016-11-30       Impact factor: 6.939

Review 7.  Surgery for obesity.

Authors:  Jill L Colquitt; Joanna Picot; Emma Loveman; Andrew J Clegg
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 8.  Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation.

Authors:  Joanna Picot; Jeremy Jones; Jill L Colquitt; Emma Loveman; Andrew J Clegg
Journal:  Obes Surg       Date:  2012-09       Impact factor: 4.129

9.  Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.

Authors:  Paulina Salminen; Mika Helmiö; Jari Ovaska; Anne Juuti; Marja Leivonen; Pipsa Peromaa-Haavisto; Saija Hurme; Minna Soinio; Pirjo Nuutila; Mikael Victorzon
Journal:  JAMA       Date:  2018-01-16       Impact factor: 56.272

10.  Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.

Authors:  Ralph Peterli; Bettina Karin Wölnerhanssen; Thomas Peters; Diana Vetter; Dino Kröll; Yves Borbély; Bernd Schultes; Christoph Beglinger; Jürgen Drewe; Marc Schiesser; Philipp Nett; Marco Bueter
Journal:  JAMA       Date:  2018-01-16       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.